格隆汇1月7日丨东诚药业(002675.SZ)公布，子公司烟台东诚北方制药有限公司（简称"东诚北方"）和烟 台东诚大洋制药有限公司（简称"东诚大洋"）收到由山东省科学技术厅、山东省工业和信息化厅、山东 省财政厅、国家税务总局山东省税务局下发的《关于公布山东省2025年度高新技术企业名单的通知》。 东诚北方被首次认定为高新技术企业，证书编号：GR202537000854，发证日期：2025年12月8日，有效 期：三年；东诚大洋被重新认定为高新技术企业，证书编号：GR202537001805，发证日期：2025年12 月8日，有效期：三年。根据《中华人民共和国企业所得税法》等相关规定，东诚北方的首次高新技术 企业认定和东诚大洋高新技术企业的重新认定，使东诚北方和东诚大洋自本次通过高新技术企业认定后 连续三年可享受国家关于高新技术企业的相关优惠政策，即按15%的税率缴纳企业所得税，不会对公司 已披露的主要财务数据和指标产生重大影响。 ...

Group 1 - The core viewpoint of the news is that three subsidiaries of Ningbo Jizhi Technology Co., Ltd. have been recognized as national high-tech enterprises, highlighting the company's innovation capabilities and core technological strength in the new materials sector [1][2]. - Ningbo Jiangbei Jizhi New Materials Co., Ltd. successfully passed the national high-tech enterprise re-evaluation, while Zhejiang Xinzhi New Materials Co., Ltd. and Ningbo Tianyuan New Materials Co., Ltd. achieved this qualification for the first time [1]. - The recognition of these companies is a significant affirmation of their innovation capabilities and reflects the overall R&D system and core technology strength of Jizhi Technology, providing strong momentum for its continued focus on the new materials field [1][2]. Group 2 - Zhejiang Xinzhi and Ningbo Tianyuan have established a comprehensive R&D system in a short period, achieving key breakthroughs in innovation development [2]. - Zhejiang Xinzhi focuses on the development and production of high-performance functional films, having successfully developed and mass-produced a series of products including ordinary diffusion plates and quantum dot diffusion plates [2]. - Ningbo Tianyuan specializes in optical adhesive films for touch displays and full lamination, having developed a range of high-performance, differentiated optical adhesive products that are now in mass production [2].

登录新浪财经APP 搜索【信披】查看更多考评等级 广州维力医疗器械股份有限公司（以下简称"公司"）全资子公司江西狼和医疗器械有限公司（以下简 称"狼和医疗"）于近日收到由江西省科学技术厅、江西省财政厅、国家税务总局江西省税务局联合颁发 的《高新技术企业证书》，具体情况如下： 证券代码：603309 证券简称：维力医疗 公告编号：2026-002 证书编号：GR202536000490 发证日期：2025年10月29日 有效期：三年 狼和医疗于2013年被认定为高新技术企业，并分别于2016年、2019年、2022年通过了复审认定，本次高 新技术企业认定是原证书有效期满后进行的重新认定。 根据《中华人民共和国企业所得税法》等有关规定，狼和医疗自获得高新技术企业认定当年起三年内 （即2025年、2026年、2027年），将继续享受国家关于高新技术企业的相关优惠政策，即按15%的税率 计缴企业所得税。 广州维力医疗器械股份有限公司 关于全资子公司通过高新技术企业 重新认定的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 本公司 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 关于公司通过高新技术企业认定的公告 本公司及董事会全体成员保证信息披露内容真实、准确和完整，没有虚假记载、误导性陈述或者重大遗 漏。 证券代码：002695 证券简称：煌上煌 编号：2026一001 江西煌上煌集团食品股份有限公司 特此公告。 江西煌上煌集团食品股份有限公司 董事会 二0二六年一月五日 近日，江西煌上煌集团食品股份有限公司（以下简称"公司"）收到江西省科学技术厅、江西省财政厅、 国家税务总局江西省税务局联合下发的《高新技术企业证书》。具体情况如下： ■ 根据《高新技术企业认定管理办法》《中华人民共和国企业所得税法》等相关规定，公司自通过高新技 术企业认定后三年内（2025年-2027年）可享受国家关于高新技术企业的相关优惠政策，即按15%的税 率缴纳企业所得税。本次通过高新技术企业认定事项不会对公司当期经营业绩产生重大影响。 ...

Core Viewpoint - *ST San Sheng (002742.SZ) announced that its wholly-owned subsidiary, Liaoyuan Baikang Pharmaceutical Co., Ltd., has received the "High-tech Enterprise Certificate" from the Jilin Provincial Department of Science and Technology, Jilin Provincial Department of Finance, and the State Taxation Administration of Jilin Province, which allows the company to enjoy a preferential corporate income tax rate of 15% for three consecutive years [1] Group 1 - Liaoyuan Baikang Pharmaceutical has been recognized as a high-tech enterprise, which qualifies it for tax benefits under the relevant national policies [1] - The company will proceed to handle the tax preferential policies with the competent tax authorities as per national regulations [1] - The tax benefits are not expected to have a significant impact on the company's current operating performance [1]

Core Viewpoint - The company, Shentong Technology (605228.SH), has received a new High-tech Enterprise Certificate for its wholly-owned subsidiary, Changchun Shentong Automotive Parts Co., Ltd., indicating its continued recognition as a high-tech enterprise in the industry [1] Group 1 - The certificate was issued by the Jilin Provincial Department of Science and Technology, Jilin Provincial Department of Finance, and the State Taxation Administration of Jilin Province [1] - The certificate number is GR202522000582, with an issuance date of December 2, 2025, and it is valid for three years [1] - This recognition follows the expiration of the previous High-tech Enterprise Certificate, indicating a successful re-evaluation process [1]

Core Viewpoint - *ST San Sheng (002742.SZ) announced that its wholly-owned subsidiary, Liaoyuan Baikang Pharmaceutical Co., Ltd. (referred to as "Baikang Pharmaceutical"), has recently received the "High-tech Enterprise Certificate" issued by the Jilin Provincial Department of Science and Technology, Jilin Provincial Department of Finance, and the State Taxation Administration of Jilin Province [1] Group 1 - Baikang Pharmaceutical will enjoy a preferential corporate income tax rate of 15% for three consecutive years after being recognized as a high-tech enterprise, according to the Corporate Income Tax Law of the People's Republic of China and relevant tax incentive policies for high-tech enterprises [1] - The company will handle the relevant tax incentive matters with the competent tax authorities in a timely manner based on national policy documents [1] - The tax incentive policy is not expected to have a significant impact on the company's current operating performance [1]

格隆汇1月5日丨步长制药(603858.SH)公布，近日，公司全资子公司通化谷红制药有限公司收到吉林省 科学技术厅、吉林省财政厅、国家税务总局吉林省税务局联合颁发的《高新技术企业证书》，通化谷红 通过高新技术企业的重新认定。 根据《中华人民共和国企业所得税法》《中华人民共和国企业所得税法实施条例》等相关规定，通化谷 红本次通过高新技术企业认定后，将连续三年享受国家关于高新技术企业所得税优惠政策，即2025年至 2027年按15%的税率缴纳企业所得税。 ...

Core Viewpoint - The company, Jizhi Technology, announced that its subsidiaries have been recognized as high-tech enterprises, which may enhance their market competitiveness and innovation capabilities [1] Group 1: Company Recognition - Jizhi Technology's subsidiary, Ningbo Jiangbei Jizhi New Materials Co., Ltd., has received a high-tech enterprise certificate with the number GR202533101861, issued on December 8, 2025, and valid for three years [1] - Another subsidiary, Zhejiang Xinzhi New Materials Co., Ltd., has also been certified as a high-tech enterprise, with certificate number GR202533100431, issued on December 8, 2025, and valid for three years [1] - Ningbo Tianyuan New Materials Co., Ltd. has been recognized as a high-tech enterprise as well, holding certificate number GR202533100405, issued on December 8, 2025, and valid for three years [1]

Core Viewpoint - Yatu High-tech Materials Co., Ltd. has faced significant delays in its IPO process, with 114 days since its approval without entering the "registration submission" phase, raising concerns about its financial integrity and operational transparency [1][2]. Financial Performance - Yatu High-tech's revenue is projected to grow from 557 million yuan in 2022 to 742 million yuan in 2024, with net profit increasing from 78 million yuan to 149 million yuan during the same period [1][2]. - The company's overseas revenue has consistently exceeded 50% of its total revenue, indicating its reliance on international markets for growth [2]. Revenue Discrepancies - There is a significant discrepancy between Yatu High-tech's reported revenue from the Russian market and the data from its local subsidiary, with differences reaching as high as 101.88% [2][3]. - The reported revenue figures for Yatu High-tech in Russia were 42.38 million yuan, 67.65 million yuan, and 96.73 million yuan for 2022, 2023, and 2024, respectively, while the official figures from the Russian tax authority were significantly lower [3]. Third-party Payment Concerns - A substantial portion of Yatu High-tech's overseas sales involves third-party payments, with amounts increasing by 109.5% over two years, raising questions about the authenticity of these transactions [4]. - The company has acknowledged that some transactions lack verifiable payment records, which has drawn scrutiny from the Beijing Stock Exchange [4]. R&D Investment and Corporate Governance - Yatu High-tech's R&D expenses are low compared to industry standards, with ratios of 3.06%, 3.63%, and 3.30% of revenue from 2022 to 2024, which barely meets the minimum requirement for high-tech enterprises [5]. - The company has a highly concentrated ownership structure, with the founding family controlling 96.5% of the shares, leading to potential governance issues [6]. Cash Dividend and Fundraising Strategy - In June 2024, Yatu High-tech distributed a cash dividend of 33.68 million yuan just before its IPO, raising questions about its need to raise an additional 35 million yuan for liquidity [6]. - Despite having sufficient cash reserves, the company claims that the fundraising is part of a long-term strategy for business expansion, indicating a potential disconnect between its financial health and its fundraising rationale [6].